Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance.

[1]  R. D. de Man,et al.  Lamivudine resistance inimmunocompetent chronic hepatitis B , 1997 .

[2]  P. Angus,et al.  Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. , 1997, Journal of hepatology.

[3]  K. Reddy,et al.  Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation , 1997, The Lancet.

[4]  Y. Kong,et al.  Regulation of HBV gene expression by core promoter and its upstream sequence , 1997 .

[5]  D. Tyrrell,et al.  Mutation in HBV RNA‐dependent DNA polymerase confers resistance to lamivudine in vivo , 1996, Hepatology.

[6]  E. Elias,et al.  Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine , 1996, Hepatology.

[7]  D. Tyrrell,et al.  Generation of duck hepatitis B virus polymerase mutants through site-directed mutagenesis which demonstrate resistance to lamivudine [(--)-beta-L-2', 3'-dideoxy-3'-thiacytidine] in vitro , 1996, Antimicrobial agents and chemotherapy.

[8]  J. A. Cromlish.  Hepatitis B virus-induced hepatocellular carcinoma: possible roles for HBx. , 1996, Trends in microbiology.

[9]  M. Wainberg,et al.  Enhanced Fidelity of 3TC-Selected Mutant HIV-1 Reverse Transcriptase , 1996, Science.

[10]  Y. Wang,et al.  Regulation of Hepatitis B Virus Gene Expression by Its Two Enhancers. , 1996, Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica.

[11]  E. Schiff,et al.  A preliminary trial of lamivudine for chronic hepatitis B infection. , 1995, The New England journal of medicine.

[12]  J. Sninsky,et al.  Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). , 1995, The Journal of infectious diseases.

[13]  E. Clercq.  HIV resistance to reverse transcriptase inhibitors , 1994 .

[14]  M. Wainberg,et al.  High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase , 1993, Antimicrobial Agents and Chemotherapy.

[15]  S D Kemp,et al.  Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Malim,et al.  Secreted placental alkaline phosphatase as a eukaryotic reporter gene. , 1992, Methods in enzymology.

[17]  R. Schinazi,et al.  Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  I Sauvaget,et al.  Identification of four conserved motifs among the RNA‐dependent polymerase encoding elements. , 1989, The EMBO journal.

[19]  P. Tiollais,et al.  Hepatitis B virus. , 1991, Scientific American.